{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:18:22Z","timestamp":1786990702133,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ijpharm.2016.07.073","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T20:20:44Z","timestamp":1469910044000},"page":"1070-1079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Design of spray dried insulin microparticles to bypass deposition in the extrathoracic region and maximize total lung dose"],"prefix":"10.1016","volume":"511","author":[{"given":"Keith T.","family":"Ung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5801-4208","authenticated-orcid":false,"given":"Nagaraja","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffry G.","family":"Weers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4128-6087","authenticated-orcid":false,"given":"Daniel","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak-Kim","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.07.073_bib0005","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.rmed.2007.06.008","article-title":"Can all patients with COPD use the correct inhalation flow with all inhalers and does training help?","volume":"101","author":"Al-Ahowair","year":"2007","journal-title":"Resp. Med."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejps.2013.08.009","article-title":"Pure insulin highly respirable powders for inhalation","volume":"51","author":"Balducci","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0015","first-page":"1","article-title":"Barth W. Design and layout of cyclone separator on the basis of new investigation","volume":"8","year":"1956","journal-title":"Brennst.-Warme-Kraft"},{"issue":"1","key":"10.1016\/j.ijpharm.2016.07.073_bib0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2500\/aap.2013.34.3648","article-title":"Particle size and small airway effects of mometasone furoate delivered by dry powder inhaler","volume":"34","author":"Berger","year":"2013","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.powtec.2012.02.047","article-title":"Improvement of the dispersibility of spray-dried budesonide powders using leucine in an ethanol\u2013water co-solvent system","volume":"236","author":"Boraey","year":"2013","journal-title":"Powder Technol."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0030","first-page":"473","article-title":"Degree of throat deposition can explain the variability in lung deposition of inhaled drugs","volume":"19","author":"Borgstr\u00f6m","year":"2006","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"issue":"11","key":"10.1016\/j.ijpharm.2016.07.073_bib0035","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1023\/A:1013082531394","article-title":"Use of solid corrugated particles to enhance powder aerosol performance","volume":"18","author":"Chew","year":"2011","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ijpharm.2016.07.073_bib0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/jam.1993.6.99","article-title":"The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers\u2014implications for in vitro testing","volume":"6","author":"Clark","year":"1993","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/089426801316970321","article-title":"In vitro monodisperse aerosol deposition in a mouth and throat with six different inhalation devices","volume":"14","author":"DeHaan","year":"2001","journal-title":"J. Aerosol Med."},{"issue":"3","key":"10.1016\/j.ijpharm.2016.07.073_bib0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1089\/jamp.2012.0975","article-title":"In vitro tests for aerosol deposition II: IVIVCs for different dry powder inhalers in normal adults","volume":"26","author":"Delvadia","year":"2013","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0055","first-page":"307","article-title":"Porous particles for inhalation: the science behind their improved dispersibility","volume":"1","author":"Dunbar","year":"2006","journal-title":"Proc. Respir. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0060","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1126\/science.276.5320.1868","article-title":"Large porous particles for pulmonary drug delivery","volume":"276","author":"Edwards","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0065","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1152\/jappl.1998.85.2.379","article-title":"Recent advances in pulmonary drug delivery using large, porous inhaled particles","volume":"85","author":"Edwards","year":"1998","journal-title":"J. Appl Physiol"},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0070","series-title":"The Mechanics of Inhaled Pharmaceutical Aerosols: An Introduction","author":"Finlay","year":"2001"},{"issue":"4","key":"10.1016\/j.ijpharm.2016.07.073_bib0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/jamp.2010.0855","article-title":"Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere\u2122 technology","volume":"24","author":"Geller","year":"2011","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijpharm.2016.07.073_bib0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1089\/dia.2007.0222","article-title":"The design and performance of the Exubera pulmonary insulin delivery system","volume":"9","author":"Harper","year":"2007","journal-title":"Diabetes Techno. & Therap."},{"issue":"6","key":"10.1016\/j.ijpharm.2016.07.073_bib0085","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s11814-011-0239-6","article-title":"Density, viscosity, and surface tension of water+ethanol mixtures from 293 to 323K","volume":"29","author":"Khattab","year":"2012","journal-title":"Korean J. Chem. Eng."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0090","first-page":"55","article-title":"Device engineering insights into TOBI Podhaler: a development case study of high efficiency powder delivery to cystic fibrosis patients","volume":"1","author":"Maltz","year":"2011","journal-title":"Proc. Respir. Drug Deliv. Europe."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0095","first-page":"669","article-title":"A novel passive dry powder inhaler for unit dose delivery to the deep lung","volume":"3","author":"Maltz","year":"2008","journal-title":"Proc. Respir. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1140\/epje\/i2008-10375-6","article-title":"Monitoring the buckling threshold of drying colloidal droplets using water-ethanol mixtures","volume":"27","author":"Marty","year":"2008","journal-title":"Eur. Phys. J E."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jamp.2012.0986","article-title":"Validation of a general in vitro approach for prediction of total lung deposition in healthy adults for pharmaceutical inhalation products","volume":"26","author":"Olsson","year":"2013","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrd2153","article-title":"Inhaling medicines: delivering drugs to the body through the lungs","volume":"6","author":"Patton","year":"2007","journal-title":"Nature Rev. Drug Discov."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0115","series-title":"The Dynamics of Fine Powder","author":"Rietema","year":"1991"},{"issue":"2","key":"10.1016\/j.ijpharm.2016.07.073_bib0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11095-006-9146-7","article-title":"Particle size analysis in pharmaceutics: principles, methods and applications","volume":"24","author":"Shekunov","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0125","first-page":"227","article-title":"Spray drying: theory and pharmaceutical applications","volume":"1","author":"Snyder","year":"2008"},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/jam.1989.2.285","article-title":"Intercomparison of experimental regional aerosol deposition data","volume":"2","author":"Stahlhofen","year":"1989","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0135","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0021-8502(99)00547-9","article-title":"On the suitability of \u03ba\u2013\u03b5 turbulence modeling for aerosol deposition in the mouth and throat: a comparison with experiment","volume":"31","author":"Stapleton","year":"2000","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0140","first-page":"627","article-title":"Effect of powder release kinetics on the performance of a dry powder inhaler","volume":"3","author":"Ung","year":"2012","journal-title":"Respir. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0145","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/02786826.2014.962685","article-title":"In vitro assessment of dose delivery performance of engineered dry powders for inhalation","volume":"48","author":"Ung","year":"2014","journal-title":"Aerosol Sci. Technol."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0150","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1023\/A:1018910200420","article-title":"Formulation and physical characterization of large porous particles for inhalation","volume":"16","author":"Vanbever","year":"1999","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.ijpharm.2016.07.073_bib0155","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s11095-007-9475-1","article-title":"Pharmaceutical particle engineering via spray drying","volume":"25","author":"Vehring","year":"2007","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ijpharm.2016.07.073_bib0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/jamp.2012.0973","article-title":"Dose emission characteristics of placebo PulmoSphere\u00ae particles are unaffected by a subject's inhalation maneuver","volume":"26","author":"Weers","year":"2013","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0165","first-page":"1","article-title":"In vitro\u2013in vivo correlations observed with indacaterol-based formulations delivered with the Breezhaler\u00ae","volume":"28","author":"Weers","year":"2015","journal-title":"J. Aerosol Med."},{"issue":"1","key":"10.1016\/j.ijpharm.2016.07.073_bib0170","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jps.21849","article-title":"Force control and powder dispersibility of spray dried particles for inhalation","volume":"99","author":"Weiler","year":"2010","journal-title":"J. Pharm Sci."},{"issue":"6","key":"10.1016\/j.ijpharm.2016.07.073_bib0175","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1089\/dia.2005.7.896","article-title":"EXUBERA\u00ae: Pharmaceutical development of a novel product for pulmonary delivery of insulin","volume":"7","author":"White","year":"2005","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.ijpharm.2016.07.073_bib0180","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/jam.2007.0584","article-title":"In vivo-in vitro comparison of deposition in three mouth-throat models with QVAR\u00ae and Turbuhaler\u00ae inhalers","volume":"20","author":"Zhang","year":"2007","journal-title":"J. Aerosol Med."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316307232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316307232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T20:02:05Z","timestamp":1568232125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316307232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0378517316307232"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.073","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of spray dried insulin microparticles to bypass deposition in the extrathoracic region and maximize total lung dose","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}